| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.27 | 3e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-05 |